Login / Signup

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke AokiTsutomu TabataSatoshi YanagidaToshiaki NakamuraAsumi OkumuraJunzo HamanishiKenichi HaranoKosei HasegawaTakeshi HirasawaKensuke HoriShinichi KomiyamaMotoki MatsuuraHidekatsu NakaiHiroko NakamuraJun SakataKazuhiro TakeharaMunetaka TakekumaYoshihito YokoyamaYoichi KaseShuuji SuminoJunpei SoedaAi KatoAjit SuriAikou OkamotoToru Sugiyama
Published in: Journal of gynecologic oncology (2024)
ClinicalTrials.gov Identifier: NCT03759600.
Keyphrases
  • dna repair
  • dna damage
  • double blind
  • open label
  • placebo controlled
  • cross sectional
  • clinical trial
  • oxidative stress
  • wild type